David J. Bowen, Wildwood, MO (US); Catherine A. Chay, Ballwin, MO (US); Todd A. Ciche, San Diego, CA (US); Uma R. Kesanapalli, Chesterfield, MO (US); and Jennifer L. Lutke, Ballwin, MO (US)
Assigned to Monsanto Technology LLC, St. Louis, MO (US)
Filed by Monsanto Technology LLC, St. Louis, MO (US)
Filed on Nov. 4, 2022, as Appl. No. 18/052,819.
Application 18/052,819 is a continuation of application No. 17/242,049, filed on Apr. 27, 2021, granted, now 11,591,612.
Application 17/242,049 is a continuation of application No. 16/179,385, filed on Nov. 2, 2018, granted, now 11,021,715, issued on Jun. 1, 2021.
Application 16/179,385 is a continuation of application No. 15/247,500, filed on Aug. 25, 2016, granted, now 10,155,960, issued on Dec. 18, 2018.
Claims priority of provisional application 62/210,737, filed on Aug. 27, 2015.
Prior Publication US 2023/0203527 A1, Jun. 29, 2023
1. A recombinant nucleic acid molecule comprising a heterologous promoter operably linked to a polynucleotide segment encoding a protein, wherein said protein comprises an amino acid sequence having the amino acid sequence as set forth in SEQ ID NO:16.